María del Mar Tavío
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
María del Mar Tavío has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Joaquim Ruiz
Universidad Científica del Sur
3 shared publications - Jordi Vila
Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto Salud Carlos III, Madrid, Spain
3 shared publications José Ruiz
Microbiology, Department of Clinical Sciences, School of Medicine, University of Las Palmas de Gran Canaria, Dr. Pasteur, 35080 Las Palmas, Spain
2 shared publicationsMaría Teresa Jiménez de Anta
Department of Microbiology Hospital Clinic School of Medicine University of Barcelona Villarroel 170 08036 Barcelona Spain
2 shared publicationsAntonio M. Martín-Sánchez
Department of Clinical Sciences School of Medicine Microbiology University of Las Palmas de Gran Canaria Dr Pasteur 35080 Las Palmas de Gran Canaria
1 shared publicationAntonio Manuel Martín-Sánchez
1 shared publication
Latest Publications
- Open Access
- 1 April 2000
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 45 (4) , 521-524
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
Ten quinolone-resistant mutants of Citrobacter freundii, which were selected in vitro with fluoroquinolones from two clinical isolates, were studied. The parent isolates were susceptible to quinolones in spite of showing a single substitution in the GyrB (His-417 → Leu). No change was observed in the outer membrane proteins or in the lipopolysaccharide in any of the ten mutants studied with respect to their parent isolates. The development of quinolone resistance in selected mutants was associated with the appearance of a substitution in the GyrA (Thr-83 → Ile) in nine of the ten mutants plus enhanced active efflux in all of them.
- 1 April 2000
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 45 (4) , 521-524
Open AccessIn vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
Ten quinolone-resistant mutants of Citrobacter freundii, which were selected in vitro with fluoroquinolones from two clinical isolates, were studied. The parent isolates were susceptible to quinolones in spite of showing a single substitution in the GyrB (His-417 → Leu). No change was observed in the outer membrane proteins or in the lipopolysaccharide in any of the ten mutants studied with respect to their parent isolates. The development of quinolone resistance in selected mutants was associated with the appearance of a substitution in the GyrA (Thr-83 → Ile) in nine of the ten mutants plus enhanced active efflux in all of them.
- 1 January 2000
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 39 (2) , 145-148
Resolution of high-molecular-weight components in lipopolysaccharides of Escherichia coli, Morganella morganii, Citrobacter freundii and Citrobacter diversus strains with sodium dodecyl sulfate polyacrylamide gels
- 1 January 2000
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 39 (2) , 145-148
Resolution of high-molecular-weight components in lipopolysaccharides of Escherichia coli, Morganella morganii, Citrobacter freundii and Citrobacter diversus strains with sodium dodecyl sulfate polyacrylamide gels
- Open Access
- 1 December 1999
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (6) , 735-742
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n= 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤12 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.
- 1 December 1999
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (6) , 735-742
Open AccessMechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n= 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤12 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.